List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
1.2 Global Glutamate Receptor Ionotropic NMDA 2B Outlook 2017 VS 2022 VS 2028
1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in US$ Million for the Year 2017-2028
1.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume for the Year 2017-2028
1.3 United States Glutamate Receptor Ionotropic NMDA 2B Outlook 2017 VS 2022 VS 2028
1.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in US$ Million for the Year 2017-2028
1.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume for the Year 2017-2028
1.4 Glutamate Receptor Ionotropic NMDA 2B Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Glutamate Receptor Ionotropic NMDA 2B in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Glutamate Receptor Ionotropic NMDA 2B Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
1.5.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
1.5.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
1.5.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges
1.5.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Type
2.1.1 JNJ-0808
2.1.2 Neu-2000
2.1.3 NP-10679
2.1.4 NP-11948
2.1.5 Radiprodil
2.1.6 Others
2.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
2.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
2.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Application
3.1.1 Acute Ischemic Stroke
3.1.2 Autism
3.1.3 Brain Ischemia
3.1.4 Burns
3.1.5 Others
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
3.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Glutamate Receptor Ionotropic NMDA 2B Competitor Landscape by Company
4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Company
4.1.1 Top Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Ranked by Revenue (2021)
4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer (2017-2022)
4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturer (2017-2022)
4.1.4 Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturer (2017-2022)
4.2 Global Glutamate Receptor Ionotropic NMDA 2B Concentration Ratio (CR)
4.2.1 Glutamate Receptor Ionotropic NMDA 2B Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Glutamate Receptor Ionotropic NMDA 2B in 2021
4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base Distribution, Product Type
4.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
4.3.3 Date of International Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Company
4.5.1 Top Glutamate Receptor Ionotropic NMDA 2B Players in United States, Ranked by Revenue (2021)
4.5.2 United States Glutamate Receptor Ionotropic NMDA 2B Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Glutamate Receptor Ionotropic NMDA 2B Sales by Players (2020, 2021 & 2022)
5 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region
5.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size in Volume by Region (2017-2028)
5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region: 2017-2022
5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Forecast by Region (2023-2028)
5.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Size in Value by Region (2017-2028)
5.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region: 2017-2022
5.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.1.2 North America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.4.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 BioCrea GmbH
7.1.1 BioCrea GmbH Corporation Information
7.1.2 BioCrea GmbH Description and Business Overview
7.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.1.5 BioCrea GmbH Recent Development
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporation Information
7.2.2 Bristol-Myers Squibb Company Description and Business Overview
7.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.2.5 Bristol-Myers Squibb Company Recent Development
7.3 Cerecor Inc.
7.3.1 Cerecor Inc. Corporation Information
7.3.2 Cerecor Inc. Description and Business Overview
7.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.3.5 Cerecor Inc. Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporation Information
7.4.2 Johnson & Johnson Description and Business Overview
7.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 Luc Therapeutics, Inc.
7.5.1 Luc Therapeutics, Inc. Corporation Information
7.5.2 Luc Therapeutics, Inc. Description and Business Overview
7.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.5.5 Luc Therapeutics, Inc. Recent Development
7.6 NeurOp, Inc
7.6.1 NeurOp, Inc Corporation Information
7.6.2 NeurOp, Inc Description and Business Overview
7.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.6.5 NeurOp, Inc Recent Development
7.7 Novartis AG
7.7.1 Novartis AG Corporation Information
7.7.2 Novartis AG Description and Business Overview
7.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.7.5 Novartis AG Recent Development
7.8 UCB S.A.
7.8.1 UCB S.A. Corporation Information
7.8.2 UCB S.A. Description and Business Overview
7.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.8.5 UCB S.A. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Glutamate Receptor Ionotropic NMDA 2B Industry Chain Analysis
8.2 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
8.3 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
8.4 Glutamate Receptor Ionotropic NMDA 2B Sales and Marketing
8.4.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels
8.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
8.5 Glutamate Receptor Ionotropic NMDA 2B Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
